Physician profile
Veda Moore
NPI 1346254414
$638.57
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $104 · 2020: $165 · 2021: $172 · 2022: $124 · 2023: $37.32 · 2024: $37.25.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $74.57.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $74.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerie Pharmaceuticals, INC. | $123.35 | 2019-2021 | |
| Biotissue Holdings INC. | $106.08 | 2022-2024 | |
| Kala Pharmaceuticals, INC. | $88.08 | 2019-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $70.07 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $56.97 | 2022 | |
| Novartis Pharmaceuticals Corporation | $49.53 | 2019-2022 | |
| Optos, INC. | $48.49 | 2021 | |
| Allergan, INC. | $29.36 | 2020 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Akorn, INC. | $19.30 | 2019 | |
| Akorn Operating Company LLC | $15.60 | 2021 | |
| Alcon Vision LLC | $12.34 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Veda Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.